Which One is More Important, Obesity or Cardio Metabolic Risk Factors?

Author Information
Article Notes and Dates
To Cite : Hosseinpanah F. Which One is More Important, Obesity or Cardio Metabolic Risk Factors?, Int J Endocrinol Metab. 2012 ;11(1):1-2. doi: 10.5812/ijem.7963.
Copyright: Copyright © 2012, International Journal of Endocrinology and Metabolism. .
Acknowledgements
Footnotes
References
  • 1. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 2004; 89(6): 2569-75[DOI][PubMed]
  • 2. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008; 168(15): 1617-24[DOI][PubMed]
  • 3. Hosseinpanah F, Barzin M, Amiri P, Azizi F. The trends of metabolic syndrome in normal-weight Tehranian adults. Ann Nutr Metab. 2011; 58(2): 126-32[DOI][PubMed]
  • 4. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009; 373(9669): 1083-96[DOI]
  • 5. Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011; 377(9771): 1085-95[PubMed]
  • 6. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006; 91(8): 2906-12[DOI][PubMed]
  • 7. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation. 2004; 109(6): 706-13[DOI][PubMed]
  • 8. Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2009; 31(6): 737-46[DOI][PubMed]
  • 9. Hosseinpanah F, Barzin M, Heikholeslami F, Azizi F. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). Am J Cardiol. 2011; 107(3): 412-6[DOI][PubMed]
  • 10. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012; 97(7): 2482-8[DOI][PubMed]
  • 11. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 2009; 32(12): 2297-9[DOI][PubMed]
  • 12. Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2012; 121(2): 230-6[DOI][PubMed]
  • 13. Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. Int J Obes (Lond). 2010; 34-23[DOI][PubMed]
  • 14. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol. 2010; 21(1): 38-43[DOI][PubMed]
  • 15. Ferket BS, Colkesen EB, Visser JJ, Spronk S, Kraaijenhagen RA, Steyerberg EW, et al. Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med. 2010; 170(1): 27-40[DOI][PubMed]
  • 16. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults,The Evidence Report. National Institutes of Health. Obes Res. 1998; 6: 51S-209S[DOI][PubMed]
  • 17. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000; 894: 1-253
  • 18. Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol. 2009; 54(14): 1209-27[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check